< Back to latest news & events

Event

Second Seminar in Salzburg, Dresden and Hamburg

July 2023

HGF is organising a German-speaking seminar series in Salzburg, Dresden, and Hamburg.

Dates
  • September 5, 2023 at 17:30 – Dresden
  • September 7, 2023 at 17:30 – Hamburg – CANCELLED
  • September 21, 2023 at 17:30 – Salzburg
About the seminar

This seminar will deal with the topic of IP strategy using well-known examples such as Lego and Thermomix.

We will explore how to use IP rights intelligently and dovetail them with the company’s wider business strategy. This will be demonstrated using well-known examples such as Lego and Thermomix. Have you put your IP strategy building blocks together correctly?

Speakers

Bernhard Ganahl – Partner & Patent Attorney

Benjamin Janutta – Patent Attorney

Jens Kienitz – Patent Attorney


Other planned seminars
  • November: License agreements
  • January: Patent search in public databases
  • March: Trademarks in practice

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article